Literature DB >> 29892959

A novel mutation in RDH5 gene causes retinitis pigmentosa in consanguineous Pakistani family.

Neelam Sultan1, Irfan Ali2,3, Shazia Anwer Bukhari1, Shahid Mahmood Baig4, Muhammad Asif5, Muhammad Qasim1, Muhammad Imran Naseer6, Mahmood Rasool6.   

Abstract

Retinitis pigmentosa (RP) is the most frequent genetically and clinically heterogeneous inherited retinal degeneration. To date, more than 80 genes have been identified that cause autosomal dominant, autosomal recessive and X linked RP. However, locus and allelic heterogeneity of RP has not been fully captured yet. This heterogeneity and lack of an accurate genotype phenotype correlation makes molecular dissection of the disease more difficult. The present study was designed to characterize the underlying pathogenic variants of RP in Pakistan. For this purpose, a large consanguineous family with RP phenotype showing autosomal recessive mode of inheritance was selected after a complete ophthalmological examination. Next generation sequencing was used for the identification of molecular determinant followed by Sanger-sequencing for confirmation. After sequence analysis a novel homozygous missense mutation, (c.602 C > T) in exon 4 of the RDH5 gene (MIM: 601617) was identified. This mutation resulted in substitution of phenyl alanine for serine at amino acid 201 (p.Ser201Phe) of the RDH5 gene. The same mutation was not detected in the 200 ethnically-matched control samples by Sanger sequencing. The identified mutant allele segregated in homozygous fashion in all the affected individuals of pedigree. Identification of this mutation reveals the allelic heterogeneity of RDH5 in patients with RP phenotype. The findings of this study demonstrate the clinical significance of next generation sequencing to understand the molecular basis of diseases and would help to reveal new proteins and their function in visual cycle will pave the way for early diagnosis, genetic counseling and better therapeutic inventions.

Entities:  

Keywords:  Missense mutation; Next generation sequencing; Pakistan; RDH5; Retinitis pigmentosa

Mesh:

Substances:

Year:  2018        PMID: 29892959     DOI: 10.1007/s13258-018-0657-5

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   1.839


  39 in total

1.  Compound heterozygous RDH5 mutations in familial fleck retina with night blindness.

Authors:  Takaaki Hayashi; Satoshi Goto-Omoto; Tomokazu Takeuchi; Tamaki Gekka; Yasuo Ueoka; Kenji Kitahara
Journal:  Acta Ophthalmol Scand       Date:  2006-04

2.  QMEAN: A comprehensive scoring function for model quality assessment.

Authors:  Pascal Benkert; Silvio C E Tosatto; Dietmar Schomburg
Journal:  Proteins       Date:  2008-04

3.  Novel RDH5 mutation in family with mother having fundus albipunctatus and three children with retinitis pigmentosa.

Authors:  Chunxia Wang; Nobuo Nakanishi; Kentaro Ohishi; Akiko Hikoya; Kenro Koide; Miho Sato; Makoto Nakamura; Yoshihiro Hotta; Shinsei Minoshima
Journal:  Ophthalmic Genet       Date:  2008-03       Impact factor: 1.803

4.  Null mutation in the human 11-cis retinol dehydrogenase gene associated with fundus albipunctatus.

Authors:  C A Driessen; B P Janssen; H J Winkens; L D Kuhlmann; A H Van Vugt; A J Pinckers; A F Deutman; J J Janssen
Journal:  Ophthalmology       Date:  2001-08       Impact factor: 12.079

5.  Cone and rod dysfunction in fundus albipunctatus with RDH5 mutation: an electrophysiological study.

Authors:  Yasuhiro Niwa; Mineo Kondo; Shinji Ueno; Makoto Nakamura; Hiroko Terasaki; Yozo Miyake
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

Review 6.  Programmed cell death in retinal degeneration: targeting apoptosis in photoreceptors as potential therapy for retinal degeneration.

Authors:  Valeria Marigo
Journal:  Cell Cycle       Date:  2007-03-17       Impact factor: 4.534

Review 7.  Mechanisms of photoreceptor death and survival in mammalian retina.

Authors:  J Stone; J Maslim; K Valter-Kocsi; K Mervin; F Bowers; Y Chu; N Barnett; J Provis; G Lewis; S K Fisher; S Bisti; C Gargini; L Cervetto; S Merin; J Peér
Journal:  Prog Retin Eye Res       Date:  1999-11       Impact factor: 21.198

Review 8.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.

Authors:  Gabriel H Travis; Marcin Golczak; Alexander R Moise; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

9.  Fundus albipunctatus in a 6-year old girl due to compound heterozygous mutations in the RDH5 gene.

Authors:  Alessandro Iannaccone; Salvatore A Tedesco; Kevin T Gallaher; Hiroyuki Yamamoto; Steve Charles; Thaddeus P Dryja
Journal:  Doc Ophthalmol       Date:  2007-05-03       Impact factor: 2.379

10.  RDH5 retinopathy (fundus albipunctatus) with preserved rod function.

Authors:  Xiaowei Liu; Liang Liu; Hui Li; Fei Xu; Ruxin Jiang; Ruifang Sui
Journal:  Retina       Date:  2015-03       Impact factor: 4.256

View more
  2 in total

1.  A large animal model of RDH5-associated retinopathy recapitulates important features of the human phenotype.

Authors:  Laurence M Occelli; Anahita Daruwalla; Samantha R De Silva; Paige A Winkler; Kelian Sun; Nathaniel Pasmanter; Andrea Minella; Janice Querubin; Leslie A Lyons; Anthony G Robson; Elise Heon; Michel Michaelides; Andrew R Webster; Krzysztof Palczewski; Ajoy Vincent; Omar A Mahroo; Philip D Kiser; Simon M Petersen-Jones
Journal:  Hum Mol Genet       Date:  2022-04-22       Impact factor: 5.121

2.  Activation of autophagy reverses progressive and deleterious protein aggregation in PRPF31 patient-induced pluripotent stem cell-derived retinal pigment epithelium cells.

Authors:  Maria Georgiou; Chunbo Yang; Robert Atkinson; Kuan-Ting Pan; Adriana Buskin; Marina Moya Molina; Joseph Collin; Jumana Al-Aama; Franziska Goertler; Sebastian E J Ludwig; Tracey Davey; Reinhard Lührmann; Sushma Nagaraja-Grellscheid; Colin A Johnson; Robin Ali; Lyle Armstrong; Viktor Korolchuk; Henning Urlaub; Sina Mozaffari-Jovin; Majlinda Lako
Journal:  Clin Transl Med       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.